It starts with a missed deadline, a forgotten appointment, or a child who simply can’t sit still in class. It’s a daily struggle that can affect school, work, relationships and self-esteem. Attention-deficit hyperactivity disorder, better known as ADHD, is one of the most diagnosed neurodevelopmental conditions, yet it remains widely misunderstood.
Once thought of as a childhood disorder defined mainly by hyperactivity, ADHD is now recognized as a complex, lifelong condition that affects both children and adults. The condition results from flaws in the way the brain regulates attention, impulse control and executive function – the mental skills that help us plan, organize and follow through on tasks.
“People often think of ADHD as simply being distracted or overly energetic,” said Amanda Horrigan, MD, a psychiatrist with Cleveland Clinic Indian River Hospital. “But it’s really about how the brain manages attention and self-regulation. It’s not a lack of willpower; it’s a difference in wiring.”
ADHD generally falls into two categories – inattention and hyperactivity-impulsivity.
For a diagnosis, symptoms must be present in at least two settings, such as home and school, and persist for six months or more. The behaviors must also interfere with academic or occupational functioning. Because early childhood development can vary widely, a formal diagnosis typically is not made before age 6.
“In a perfect world, every child [thought to have ADHD] would receive a full psychiatric evaluation,” Dr. Horrigan said. “That includes an in-depth look at other possible factors like anxiety, depression, learning differences or social challenges. We also use standardized rating scales, but it’s critical to gather information from multiple sources – not just parents, but teachers as well – so we can see how the child functions in different environments.”
Even with careful evaluation, diagnosing ADHD is not always straightforward. There is no single test, no bloodwork or brain scan, that can confirm it. Instead, clinicians rely on detailed histories, behavioral assessments, and established diagnostic criteria, while also ruling out other conditions that can mimic ADHD, such as sleep disorders, anxiety, depression and thyroid issues.
Research suggests genetics plays a significant role, as ADHD often runs in families.
Environmental factors may also contribute. Premature birth, low birth weight and prenatal exposure to substances like tobacco or alcohol have all been linked to an increased risk.
Boys are more frequently diagnosed in childhood, often because their symptoms are more outwardly disruptive. Girls, by contrast, may be more likely to daydream, struggle quietly, or internalize their difficulties, leading to delayed or missed diagnoses.
In adults, ADHD often looks different. Hyperactivity may diminish, but challenges with organization, time management and task completion can persist. Many adults describe a lifelong sense of underachievement despite their abilities. It’s not uncommon for people to reach their 30s, 40s or beyond before receiving a diagnosis that finally explains years of frustration.
Once diagnosed, treatment is highly individualized. For many, medication plays a central role. Stimulant medications are among the most commonly prescribed. They work by increasing levels of certain neurotransmitters in the brain, helping to improve focus and reduce impulsivity. Non-stimulant options are also available for those who cannot tolerate stimulants or have certain medical conditions.
At the same time, there are concerns about overprescribing and misuse of drugs that target the condition. Because stimulant medications can enhance focus even in individuals without ADHD, there is a potential for misuse, particularly among students and professionals seeking a performance edge. Careful screening and ongoing monitoring are essential components of responsible prescribing.
Over the past two decades, ADHD diagnoses in children have increased significantly, with current estimates suggesting that more than 11 percent of children ages 3 to 17 have been diagnosed.
Adult diagnoses also have increased, nearly doubling in recent years.
Medication is only one piece of the puzzle. Behavioral therapy, coaching and lifestyle changes all can play a critical role in managing symptoms. Structured routines, regular exercise, adequate sleep and minimizing distractions can make a meaningful difference.
For children, parent training and school-based interventions often are key components of treatment.
Despite its challenges, ADHD has benefits, too. Many individuals with ADHD are creative, energetic and capable of innovative, big-picture thinking. In the right environment, these traits can become powerful assets.
“ADHD starts in childhood and impacts brain development and function,” Dr. Horrigan said.
“There are differences in brain structure, connectivity and chemistry. Unfortunately, traditional school settings are not always designed for kids with ADHD. Sitting still for long periods can be incredibly difficult. These children often need movement breaks and more flexible approaches to learning.”
Still, she emphasized, the goal is not to “fix” someone with ADHD.
“ADHD brains are often wired for creativity and innovation,” she said. “The goal is to help individuals harness their strengths while managing the areas that are more challenging.”
Research into ADHD continues to expand, offering hope for more precise diagnostics and increasingly personalized treatments. In recent years, new approaches have begun to move beyond traditional medication and behavioral strategies, embracing technology and biology in ways that align more closely with how the ADHD brain works.
Among the most promising developments is the rise of pharmacogenetic testing which analyzes how a person’s genetic makeup influences their response to medication. By examining how genes affect medication metabolism, clinicians can better predict which stimulants are likely to be effective and which may cause unwanted side effects, reducing the trial-and-error process that has long defined ADHD treatment.
Researchers are also identifying biological markers that may help guide care. These include EEG patterns that can indicate whether an individual is more likely to respond to stimulant or non-stimulant medications, as well as cognitive testing profiles that help tailor treatment combinations.
A new generation of digital therapy apps uses artificial intelligence to track symptoms and detect patterns that may not be immediately obvious. These platforms can anticipate when support may be needed, suggest adjustments in daily routines, and even help optimize medication timing based on an individual’s natural biorhythms. Many also provide real-time coping strategies, offering guidance when needed.
Even virtual reality is stepping into the clinical landscape. VR-based therapies create immersive, controlled environments where individuals can practice executive functioning skills, like focus, organization and impulse control in realistic scenarios. For many with ADHD, the interactive and engaging nature of virtual reality makes it an especially effective tool for learning and retention.
According to research from the National Institute of Mental Health, these innovations are already showing measurable improvements in treatment outcomes. More importantly, they reflect a broader shift in how ADHD is understood, not as a deficit to be corrected, but as a difference to be supported with precision and care.
“New frontiers in pharmacological treatment of attention-deficit hyperactivity disorder,” a June 2025 study archived in the National Library of Medicine, found that “a multidisciplinary approach that integrates pharmacotherapy, behavioral therapy and novel technology-based interventions holds promise for improving patient outcomes and addressing the societal impact of ADHD.
Amanda Horrigan, MD, is board certified in Adult, Child and Adolescent and Forensic Psychiatry. She sees patients at the Behavioral Health Center, part of Cleveland Clinic Indian River Hospital. For more information on programs offered at the CCIRH Behavior Health Center, call 772-563-4666 or visit my.clevelandclinic.org/florida/departments/neurological/depts/behavioral-health-center.
